Nu Skin Enterprises (NUS) Common Equity (2009 - 2026)

Nu Skin Enterprises has disclosed Common Equity across 18 years of filings, most recently posting $794.1 million for Q1 2026.

• Common Equity for Q1 2026 came in at $794.1 million, up 5.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $794.1 million (up 5.32% YoY), and the FY2025 annual result was $805.2 million, up 23.61% from the prior year.
• Common Equity came in at $794.1 million for Q1 2026 at Nu Skin Enterprises, down from $805.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $941.0 million in Q2 2022 to a low of $651.5 million in Q4 2024.
• The 5-year median for Common Equity is $810.2 million (2024), against an average of $814.3 million.
• Across the five-year window, Common Equity dropped 23.36% in 2024 and rose 23.61% in 2025, its largest moves.
• Nu Skin Enterprises' Common Equity stood at $897.3 million in 2022, then dropped by 8.4% to $822.0 million in 2023, then slipped by 20.74% to $651.5 million in 2024, then grew by 23.61% to $805.2 million in 2025, then slipped by 1.39% to $794.1 million in 2026.
• The last three Common Equity figures came in at $794.1 million (Q1 2026), $805.2 million (Q4 2025), and $799.8 million (Q3 2025), per Business Quant data.